Spanish Red Biotech Pipeline

Amgen

blinatumomab

Type: Biodrugs/ Drugs
Therapeutic area: Blood and Lymphatic systems
Cancer
Indication: Refractory/Relapsed Precursor B-Acute Lymphoblastic Leukemia (B-ALL R/R)
Phase: 1Phase I in Spain